The use of electroporation to deliver DNA-based vaccines

IF 5.5 3区医学 Q1 IMMUNOLOGY

Expert Review of Vaccines Pub Date : 2023-12-08 DOI:10.1080/14760584.2023.2292772

Igor M. Belyakov, Denis N Kisakov, Lubov A Kisakova, Vladimir A Yakovlev, Elena V Tigeeva, Larisa I Karpenko

引用次数: 0

Abstract

Nucleic acids represent a promising platform for creating vaccines, including against COVID-19. One disadvantage of this approach is its relatively low immunogenicity. Electroporation (EP) is an ef...

查看原文本刊更多论文

利用电穿孔技术提供 DNA 疫苗

核酸是制造疫苗（包括针对 COVID-19 的疫苗）的理想平台。这种方法的一个缺点是免疫原性相对较低。电穿孔（EP）是一种有效的疫苗制造方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Vaccines 医学-免疫学

CiteScore

9.10

自引率

3.20%

发文量

136

审稿时长

4-8 weeks

期刊介绍： Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.